Andere talen Axsome Therapeutics, Inc.

Aandelen

AXSM

US05464T1043

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 21-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
76,39 ^USD	+1,61%		+3,75%	-4,02%

05/06	AXSOME THERAPEUTICS, INC. : RBC Capital Markets handhaaft koopadvies	ZM
05/06	Axsome Therapeutics zegt dat het een schikking heeft getroffen in Sunosi octrooigeschil met Unichem Laboratories	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Axsome therapeutics settles sunosi patent litigation with unichem laboratories	06/06
Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories	05/06
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories	05/06
Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month	04/06
Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month	04/06
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month	03/06
Axsome Therapeutics to Participate in Upcoming Investor Conferences	30/05
Axsome Therapeutics to Participate in Upcoming Investor Conferences	30/05
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024	29/05
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting	28/05
Axsome Therapeutics to Present at Upcoming Investor Conferences	08/05
Axsome Therapeutics to Present at Upcoming Investor Conferences	08/05
Axsome Therapeutics Q1 Loss Widens, Revenue Declines -- Shares Advance Pre-Bell	06/05
Axsome: Q1 Earnings Snapshot	06/05
Earnings Flash (AXSM) AXSOME THERAPEUTICS Posts Q1 Revenue $75M, vs. Street Est of $72.9M	06/05
Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	06/05
Axsome Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05
North American Morning Briefing : Stock Futures Rise as Hopes of Rate Cut Return	06/05
Axsome Therapeutics Recognizes May as Mental Health Awareness Month	01/05
North American Morning Briefing : More Earnings -2-	30/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Axsome Therapeutics, Inc.

Aandelen

AXSM

US05464T1043

Andere talen

Filters